BBLG

Business Context and Reporting Period

Company: AFH Acquisition X, Inc. (Note: Input metadata referenced "Bone Biologics Corp," but the filing text identifies the registrant as AFH Acquisition X, Inc.)
Reporting Period: Fiscal year ended October 31, 2009.
Business Model: The Company is a "blank check" shell company incorporated in Delaware on October 18, 2007. It has no specific business plan other than to pursue a business combination (merger or acquisition) with an unidentified target company. As of the filing date, the Company has not conducted negotiations or entered into any letters of intent regarding a target business.

Key Financial Metrics

Debt and Liquidity: The Company has no formal debt but owes $14,770 to its parent company (AFH Holding & Advisory, LLC) and $5,681 in accrued expenses. As of October 31, 2009, the Company held zero cash and cash equivalents.

Material Changes vs. Prior Period

• Liquidity Deterioration: Cash and cash equivalents decreased from $3,076 in 2008 to $0 in 2009. Total assets dropped from $5,159 to $0.
• Liability Increase: Total liabilities increased by approximately 33.5% from $15,325 in 2008 to $20,451 in 2009, driven by an increase in amounts due to the parent company and accrued expenses.
• Operating Loss: The net loss for 2009 was $10,285, a decrease in loss magnitude compared to the $13,343 loss in 2008. Expenses were primarily legal, accounting, and audit fees related to regulatory filings.
• Going Concern: The Company's auditors have issued a report stating that the Company's significant operating losses and lack of cash raise substantial doubt about its ability to continue as a going concern.

Guidance, Outlook, and Risks

Outlook: The Company anticipates incurring costs related to filing Exchange Act reports and investigating potential acquisitions over the next 12 months. Management expects to fund these costs through treasury funds (currently depleted), deferral of fees, or loans/investments from stockholders and management. There is no assurance that funding will be available.

Risks and Contingencies:

• Shell Company Status: The Company is a shell company with nominal assets and no operations. It relies entirely on a future business combination to generate value.
• Going Concern: The Company has an accumulated deficit of $45,451 and no revenue. Continued operations depend on external financing.
• Dilution: In a potential acquisition, existing shareholders may be significantly diluted if the transaction is structured as a tax-free reorganization where target owners retain 80% or more of the voting stock.
• Management Concentration: The Company has no employees other than its sole officer and director, Amir F. Heshmatpour, who devotes limited time to the Company until an acquisition is identified.

Investor Verification Checklist

• Capital Adequacy: Verify if the parent company or management has committed to providing additional funding to cover the $20,451 in liabilities and ongoing operational costs, given the $0 cash balance.
• Acquisition Progress: Confirm if any definitive agreements or letters of intent have been signed since the filing date, as the Company currently has no target.
• Related Party Transactions: Review the terms of the $14,770 owed to the parent company (AFH Holding & Advisory, LLC) to understand repayment obligations and potential conflicts of interest.
• Stock Ownership: Note that 100% of the 5,000,000 outstanding shares are beneficially owned by the sole officer/director via an LLC, leaving no public float.
• Audit Opinion: Acknowledge the "substantial doubt" regarding the going concern status expressed by the independent auditors (EFP Rotenberg, LLP).